Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Paclitaxel Sets

K-Number: K160007 · 2016-12-19

Decision Date2016-12-19
Product CodeFPA
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

Paclitaxel Sets is a medical device manufactured by Baxter Healthcare Corporation. It received FDA 510(k) clearance on 2016-12-19 under approval number K160007. The device is classified under product code FPA. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Paclitaxel Sets?

Paclitaxel Sets is a medical device that received FDA 510(k) clearance on 2016-12-19. It is manufactured by Baxter Healthcare Corporation. The 510(k) number is K160007.

When was Paclitaxel Sets approved by the FDA?

Paclitaxel Sets received FDA 510(k) clearance on 2016-12-19, under approval number K160007.

What company makes Paclitaxel Sets?

Paclitaxel Sets is manufactured by Baxter Healthcare Corporation.

What is the FDA product code for Paclitaxel Sets?

The FDA product code for Paclitaxel Sets is FPA.

Other Devices by Baxter Healthcare Corporation

View all 48 devices →

Related Devices (Code: FPA)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.